India recently added three new Covid-19 shots to its bank of vaccines against coronavirus, namely SII's Covovax and Biological E's Corbevax. A third "anti-viral" drug Molnupiravir has also been added to the arsenal. The three drugs have been given emergency use approval (EUA) by the Central Drug Authority, India's apex drug regulatory body on Tuesday.